U.S. Markets open in 7 hrs 38 mins
  • S&P Futures

    3,449.25
    +17.00 (+0.50%)
     
  • Dow Futures

    28,311.00
    +129.00 (+0.46%)
     
  • Nasdaq Futures

    11,702.25
    +41.50 (+0.36%)
     
  • Russell 2000 Futures

    1,624.60
    +9.80 (+0.61%)
     
  • Crude Oil

    41.51
    +0.05 (+0.12%)
     
  • Gold

    1,920.30
    +4.90 (+0.26%)
     
  • Silver

    25.13
    +0.15 (+0.60%)
     
  • EUR/USD

    1.1854
    +0.0025 (+0.2134%)
     
  • 10-Yr Bond

    0.7970
    0.0000 (0.00%)
     
  • Vix

    29.35
    +0.17 (+0.58%)
     
  • GBP/USD

    1.2978
    +0.0031 (+0.2414%)
     
  • USD/JPY

    105.2940
    -0.1760 (-0.1669%)
     
  • BTC-USD

    12,255.78
    +1,198.77 (+10.84%)
     
  • CMC Crypto 200

    246.19
    +7.28 (+3.05%)
     
  • FTSE 100

    5,889.22
    +4.57 (+0.08%)
     
  • Nikkei 225

    23,656.96
    +89.92 (+0.38%)
     

CLASS ACTION UPDATE for ENDP, CODX and BAYRY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

·4 mins read

NEW YORK, NY / ACCESSWIRE / August 13, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

ENDP Shareholders Click Here: https://www.zlk.com/pslra-1/endo-international-plc-loss-submission-form?prid=8548&wire=1
CODX Shareholders Click Here: https://www.zlk.com/pslra-1/co-diagnostics-inc-loss-submission-form?prid=8548&wire=1
BAYRY Shareholders Click Here: https://www.zlk.com/pslra-1/bayer-aktiengesellschaft-loss-submission-form?prid=8548&wire=1

* ADDITIONAL INFORMATION BELOW *

Endo International Plc (NASDAQ:ENDP)

ENDP Lawsuit on behalf of: investors who purchased August 8, 2017 - June 10, 2020
Lead Plaintiff Deadline: August 18, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/endo-international-plc-loss-submission-form?prid=8548&wire=1

According to the filed complaint, during the class period, Endo International Plc made materially false and/or misleading statements and/or failed to disclose that: (i) Endo's and/or its subsidiaries' contributions to the opioid crisis (including, but not limited to, their opioid products' disproportionately negative impact on New York and the fraud that Defendants perpetrated on the New York insurance market) were larger in scope than the Company had represented; (ii) part of that contribution to the crisis included Endo publishing and disseminating false information to health care providers regarding the risks and benefits of opioids; (iii) the foregoing, once revealed, was foreseeably likely to subject Endo and/or its subsidiaries to increased regulatory scrutiny and enforcement, as well as significant financial and/or reputational harm, particularly with respect to New York; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Co-Diagnostics, Inc. (NASDAQ:CODX)

CODX Lawsuit on behalf of: investors who purchased February 25, 2020 - May 15, 2020
Lead Plaintiff Deadline: August 17, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/co-diagnostics-inc-loss-submission-form?prid=8548&wire=1

According to the filed complaint, Co-Diagnostics and its directors and officers (including PhD-level scientists who should know better) made continual, knowing, and willful misstatements about the Company's main product, a Covid-19 diagnostic test. These misstatements had the effect of pumping up the price of Co-Diagnostics' stock, while Company officers and directors exercised low-priced options and dumped their stock into the market. Co-Diagnostics' fraudulent misstatements displayed a disregard for basic scientific principles and caused investors to lose millions of dollars.

Bayer Aktiengesellschaft (OTCPINK:BAYRY)

Lawsuit on behalf of all persons or entities that purchased or otherwise acquired Bayer American Depositary Receipts between May 23, 2016 and March 19, 2019.
Lead Plaintiff Deadline: September 14, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/bayer-aktiengesellschaft-loss-submission-form?prid=8548&wire=1

According to the filed complaint, 1) following its acquisition of Monsanto Company, Bayer could be at risk of suffering billions of dollars in judgments and reputational damage if the lawsuits brought against Monsanto alleging that exposure to its glyphosate-based Roundup product caused cancer were successful, 2) a result, Defendants' positive statements about the prospects of the Monsanto acquisition and the benefits it would create for Bayer's business were materially false and/or misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington, D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
http://www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/601581/CLASS-ACTION-UPDATE-for-ENDP-CODX-and-BAYRY-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders